Researchers At Stanford Create A Novel Cancer Treatment
The molecule tigilanol tiglate, also known as EBC-46, could provide tailored treatment for diseases including cancer, as according research from Stanford University in the...
Vaccination Partnership Formed Between Ziphius And UZ Ghent
A public-private partnership between UZ Ghent and Ziphius Vaccines, a firm producing vaccines and treatments based on self-amplifying RNA (saRNA), has been announced. The...
NPA And Charac Work Together To Hasten Digital Transition
The National Pharmacy Association (NPA) and Charac, an NHS-integrated one-stop gateway for independent community pharmacists, have established a long-term cooperation to enable pharmacies to...
The User Fees At The FDA Have Been Authorized Once Again
As anticipated, four important user fee programmes were renewed by Congress for the week ending October 1st as part of a bill that was...
Jemperli From GSK Beats Keytruda In Lung Cancer Head-To-Head
The standard therapy for newly diagnosed metastatic non-small cell lung cancer is Keytruda by Merck. That is the standard that PD-1 latecomer GSK's Jemperli...
The Solution To Neurological Problems May Lie In Junk DNA
According to recent studies, there is a connection between non-coding DNA and some neurological diseases such as Alzheimer's and motor neurone disease.
Researchers from the...
The FDA Increases Patient Input During Drug Development
The FDA started a programme ten years ago to increase the role of patients in educating sponsors and regulators on the most detrimental impacts...
Subscribe Our Newsletter
White Papers
The Future of Digital Health
The pharmaceutical industry is acutely aware that the future of health and care, particularly in the United States, are trending toward a digital revolution....
Five Best Practices to Deliver Exceptional Multichannel Experiences
A one-size-fits-all customer journey no longer works. In the age of the consumer, the quality of the interaction is paramount. In this paper, we...
The Impact and Use of Social Media in Pharmacovigilance
Social media presents new channels and methods for biopharmaceutical companies to move away from traditional pharmacovigilance (PV) systems and safety reporting methods towards more...